NGRC On Other Exchanges

national graphite corp (NGRC) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

national graphite corp (NGRC) Related Businessweek News

No Related Businessweek News Found

national graphite corp (NGRC) Details

National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company. The company collaborates with clinical stage companies that develop new biological entities or new therapeutically platforms for the treatment of various diseases, rare diseases, and diseases with unmet needs. It is developing a drug candidate called ELAFIN, which is a human identic protein for the treatment of postoperative inflammatory complications. National Graphite Corp. has a collaboration agreement with Proteo Inc. for developing ELAFIN. The company was formerly known as Lucky Boy Silver Corporation and changed its name to National Graphite Corp. in May 2012. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany.

national graphite corp (NGRC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

national graphite corp
National Graphite Corp., Annual General Meeting, Jun 25, 2018

National Graphite Corp., Annual General Meeting, Jun 25, 2018, at 11:00 Eastern Daylight. Location: Corporation's office at Suite 201, 290 Picton Avenue Ottawa Ontario Canada Agenda: To receive the audited financial statements of the Corporation for the fiscal year ended December 31, 2017, together with the report of the auditors thereon; to elect the directors of the Corporation for the ensuing year; to appoint MNP LLP, Chartered Professional Accountants, as auditors of the Corporation and to authorize the directors of the Corporation to fix the auditors' remuneration; to consider and, if deemed appropriate, to approve, with or without variation, an ordinary resolution approving the Corporation's stock option plan, as amended and restated, as more particularly described in the accompanying management information circular; and to transact such further or other business as may properly come before the Meeting or any adjournment or adjournments thereof.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

NGRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NGRC.
View Industry Companies

Industry Analysis


Industry Average

Valuation NGRC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NATIONAL GRAPHITE CORP, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at